Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05750264 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intravenous Ibuprofen Postoperative Analgesia After Abdominal Hysterectomy

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 4 months later Dec 2025 → May 2027
See other at-risk trials from Menoufia University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 2025 to May 2027
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 2 of 10 entries
  2. Primary and study completion dates: Apr 2025 to Dec 2025v8
  3. Primary and study completion dates: Apr 2024 to Apr 2025v7
  4. Primary and study completion dates: Dec 2023 to Apr 2024v6
  5. Primary and study completion dates: Nov 2023 to Dec 2023v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary and study completion dates: Sep 2023 to Nov 2023v4
  2. Primary and study completion dates: Jul 2023 to Sep 2023v3
  3. Trial status: Recruiting to Active, Not Recruiting
    • Start date changed from estimate of Feb 22, 2023 to Mar 4, 2023
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The current research is designed to investigate the analgesic efficacy of intravenous ibuprofen on the postoperative analgesic requirements, pain intensity and other recovery parameters.
Trial Details
NCT Number NCT05750264
Lead Sponsor Menoufia University
Conditions
(from sponsor)		 Post Operative Analgesia
Enrollment 152 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov